Evidence map›Paper›PMID 37259478›Full record

ArticleAnnals of clinical and translational neurology2023

Inappropriate interpretation of non-pathogenic HTRA1 variant as pathogenic.

Masahiro Uemura, Sho Kitahara, Taisuke Kato, Hiroaki Nozaki, Shoichiro Ando, Tomohiko Ishihara, Osamu Onodera

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Masahiro UemuraDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0003-0645-0099
Sho KitaharaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Taisuke KatoDepartment of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan.
Hiroaki NozakiDepartment of Medical Technology, Graduate School of Health Sciences, Niigata University, Niigata, Japan.
Shoichiro AndoDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0002-5852-9893
Tomohiko IshiharaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0001-9915-8665
Osamu OnoderaDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.ORCID 0000-0003-3354-5472

Funding

Japan Agency for Medical Research and Development 19ek0109236h0003Japanese Ministry of Health, Labor and Welfare 21FC0201Ministry of Education, Culture, Sports, Science and Technology 19H01043Ministry of Education, Culture, Sports, Science and Technology 26117006Takeda Science Foundation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37259478
PMCPMC10351663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.